原发性与二次抗反流手术90天内死亡率、再手术率及住院时间:一项基于人群的多国研究
高龄和合并症增加死亡及住院延长风险,高医院年手术量可能降低原发手术住院延长风险。
要点
- 原发腹腔镜抗反流手术90天死亡率0.13%,再手术率3.0%。
- 二次抗反流手术90天死亡率0.19%,再手术率6.2%。
- 高龄和合并症增加死亡及住院延长风险,高手术量中心风险更低。
核心结论
- 腹腔镜抗反流手术治疗胃食管反流病总体安全性良好,尤其适用于无严重合并症的年轻患者在高手术量中心接受手术。
研究设计与样本
- 基于人群的队列研究,纳入2000-2018年北欧五国接受原发性腹腔镜或二次抗反流手术的患者。
主要发现
- 原发手术(n=26193)90天死亡率为0.13%(n=35),再手术率为3.0%(n=750)。
- 原发手术后90天死亡风险:年龄56-80岁 vs 18-42岁 OR 2.66(95%CI 1.03-6.85);Charlson合并症指数≥2 vs 0 OR 6.25(95%CI 2.42-16.14);医院年手术量最高 vs 最低三分位 OR 0.58(95%CI 0.22-1.57)。
- 合并症增加90天再手术风险;高龄和合并症增加原发及二次手术后住院延长风险。
- 原发手术后住院延长风险:医院年手术量最高 vs 最低三分位 OR 0.74(95%CI 0.67-0.80)。
临床怎么用
- 术前应评估年龄和合并症,高龄或严重合并症患者手术风险较高。
- 建议在高手术量中心实施抗反流手术以降低住院延长风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Absolute rates and risk factors of short-term outcomes after antireflux surgery remain largely unknown. We aimed to clarify absolute risks and risk factors for poor 90-day outcomes of primary laparoscopic and secondary antireflux surgery. METHODS: This population-based cohort study included patients who had primary laparoscopic or secondary antireflux surgery in the 5 Nordic countries in 2000-2018. In addition to absolute rates, we analyzed age, sex, comorbidity, hospital volume, and calendar period in relation to all-cause 90-day mortality (main outcome), 90-day reoperation, and prolonged hospital stay (≥2 days over median stay). Multivariable logistic regression provided odds ratios (ORs) with 95% confidence intervals (95% CI), adjusted for confounders. RESULTS: Among 26,193 patients who underwent primary laparoscopic antireflux surgery, postoperative 90-day mortality and 90-day reoperation rates were 0.13% (n = 35) and 3.0% (n = 750), respectively. The corresponding rates after secondary antireflux surgery (n = 1 618) were 0.19% (n = 3) and 6.2% (n = 94). Higher age (56-80 years vs 18-42 years: OR, 2.66; 95% CI 1.03-6.85) and comorbidity (Charlson Comorbidity Index ≥2 vs 0: OR, 6.25; 95% CI 2.42-16.14) increased risk of 90-day mortality after primary surgery, and higher hospital volume suggested a decreased risk (highest vs lowest tertile: OR, 0.58; 95% CI, 0.22-1.57). Comorbidity increased the risk of 90-day reoperation. Higher age and comorbidity increased risk of prolonged hospital stay after both primary and secondary surgery. Higher annual hospital volume decreased the risk of prolonged hospital stay after primary surgery (highest vs lowest tertile: OR, 0.74; 95% CI, 0.67-0.80). CONCLUSION: These findings suggest that laparoscopic antireflux surgery has an overall favorable safety profile in the treatment of gastroesophageal reflux disease, particularly in younger patients without severe comorbidity who undergo surgery at high-volume centers.
引用
- Yanes M, Santoni G, Maret-Ouda J, et al. Mortality, Reoperation, and Hospital Stay Within 90 Days of Primary and Secondary Antireflux Surgery in a Population-Based Multinational Study. Gastroenterology. 2021. PMID: 33587926. doi:10.1053/j.gastro.2021.02.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。